Euro-Med Laboratories Phil., Inc. Sustainability Profile
Euro-Med Laboratories Phil., Inc., commonly referred to as Euro-Med, is a leading player in the pharmaceutical and healthcare industry, headquartered in the Philippines. Established in 1992, the company has made significant strides in providing high-quality medical products and services across the Asia-Pacific region. Specialising in the distribution of pharmaceuticals, medical devices, and diagnostic products, Euro-Med is recognised for its commitment to innovation and quality. The company’s core offerings include a diverse range of healthcare solutions that cater to the evolving needs of healthcare professionals and patients alike. With a strong market presence, Euro-Med has achieved notable milestones, including partnerships with renowned global manufacturers. This positions the company as a trusted provider in the healthcare sector, dedicated to enhancing patient care through reliable and effective medical solutions.
DitchCarbon Score
How does Euro-Med Laboratories Phil., Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Euro-Med Laboratories Phil., Inc.'s score of 27 is lower than 55% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Euro-Med Laboratories Phil., Inc.'s reported carbon emissions
In 2023, Euro-Med Laboratories Phil., Inc. reported total carbon emissions of approximately 20,382,210 kg CO2e. This figure includes 7,803,600 kg CO2e from Scope 1 emissions and 12,578,610 kg CO2e from Scope 2 emissions. The company has shown a slight decrease in emissions compared to 2022, where total emissions were approximately 19,575,000 kg CO2e, comprising 7,932,000 kg CO2e from Scope 1 and 11,643,000 kg CO2e from Scope 2. Euro-Med Laboratories Phil., Inc. does not currently disclose Scope 3 emissions data, and there are no specific reduction targets or climate pledges outlined in their sustainability initiatives. The emissions data is cascaded from the parent company, Euro-Med Laboratories Phil., Inc., indicating a corporate family relationship that influences their reporting. The company continues to monitor its carbon footprint and is committed to improving its sustainability practices, although specific reduction initiatives or targets have not been detailed.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 5,719,205 | 0,000,000 | 0,000,000 |
| Scope 2 | 10,889,972 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - |
How Carbon Intensive is Euro-Med Laboratories Phil., Inc.'s Industry?
How Carbon Intensive is Euro-Med Laboratories Phil., Inc.'s Location?
Euro-Med Laboratories Phil., Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Euro-Med Laboratories Phil., Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
